4.22
price down icon0.71%   -0.03
after-market After Hours: 4.09 -0.13 -3.08%
loading
Organogenesis Holdings Inc stock is traded at $4.22, with a volume of 626.94K. It is down -0.71% in the last 24 hours and down -15.09% over the past month. Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.25
Open:
$4.2
24h Volume:
626.94K
Relative Volume:
0.35
Market Cap:
$549.17M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
118.21
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
+12.53%
1M Performance:
-15.09%
6M Performance:
+37.46%
1Y Performance:
+51.25%
1-Day Range:
Value
$4.105
$4.31
1-Week Range:
Value
$3.57
$4.39
52-Week Range:
Value
$2.165
$6.71

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name
Name
Organogenesis Holdings Inc
Name
Phone
781-575-0775
Name
Address
85 DAN ROAD, CANTON, MA
Name
Employee
869
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
ORGO's Discussions on Twitter

Compare ORGO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ORGO
Organogenesis Holdings Inc
4.22 549.17M 433.14M 4.95M 6.55M 0.0357
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
148.67 67.28B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.22 45.62B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.71 45.01B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
13.65 15.60B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
284.73 12.77B 2.76B 1.11B 898.10M 22.77

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-28-24 Initiated Lake Street Buy
Feb-07-24 Initiated Cantor Fitzgerald Overweight
Jun-15-23 Initiated Morgan Stanley Equal-Weight
May-24-23 Upgrade BTIG Research Neutral → Buy
Nov-10-22 Downgrade BTIG Research Buy → Neutral
Aug-10-22 Downgrade Oppenheimer Outperform → Perform
Jan-10-20 Initiated SVB Leerink Outperform
Aug-26-19 Resumed Credit Suisse Outperform
May-02-19 Initiated Credit Suisse Outperform
Apr-17-19 Initiated Oppenheimer Outperform
Apr-11-19 Initiated SunTrust Buy
View All

Organogenesis Holdings Inc Stock (ORGO) Latest News

pulisher
Apr 18, 2025

Amniotic Membrane Market Set to Witness Significant Growth - openPR.com

Apr 18, 2025
pulisher
Apr 15, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by American Century Companies Inc. - Defense World

Apr 14, 2025
pulisher
Apr 11, 2025

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - The Manila Times

Apr 11, 2025
pulisher
Apr 11, 2025

Medicare Coverage Shift for Wound Care Products Paused: What This Means for Patient Access - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

Sei Investments Co. Cuts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

High Growth Tech Stocks In The US To Watch April 2025 - simplywall.st

Apr 08, 2025
pulisher
Apr 08, 2025

Prudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - The Manila Times

Apr 07, 2025
pulisher
Apr 07, 2025

Organogenesis Sets Key Q1 Earnings Date: What Investors Should Watch - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

Insider-Favored Growth Companies Including Organogenesis Holdings And Two More - simplywall.st

Apr 04, 2025
pulisher
Apr 02, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022ORGO - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Invests $38,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 02, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Has $2.96 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Organogenesis Highlights Strategic Focus in Investor Presentation - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Wound Care Biologics Market Overall Study Report 2025-2032 | - openPR.com

Mar 26, 2025
pulisher
Mar 24, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Position Raised by Bank of New York Mellon Corp - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Purchases 109,762 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - The AM Reporter

Mar 24, 2025
pulisher
Mar 23, 2025

Organogenesis Holdings Inc.(NasdaqCM:ORGO) added to S&P Biotechnology Select Industry Index - MarketScreener

Mar 23, 2025
pulisher
Mar 17, 2025

Organogenesis Holdings: Solid Finances Protect From Uncertain Environment (NASDAQ:ORGO) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 16, 2025

Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% – What’s Next? - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Analyzing Organogenesis (NASDAQ:ORGO) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Mar 16, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Acquires 7,621 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Morgan Stanley Increases Organogenesis (NASDAQ:ORGO) Price Target to $6.00 - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Organogenesis director Michael Driscoll sells $127,535 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Organogenesis director Michael Driscoll sells $127,535 in stock - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

High Growth Stocks Insiders Are Eager To Own - Simply Wall St

Mar 06, 2025
pulisher
Mar 06, 2025

Organogenesis (NASDAQ:ORGO) Trading 9.1% Higher on Analyst Upgrade - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Best Growth Stocks To Watch Now – March 1st - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ORGO, MARA and OSH - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Best Small Cap Stocks To Follow NowMarch 2nd - MarketBeat

Mar 02, 2025
pulisher
Mar 02, 2025

Small Cap Stocks To Keep An Eye OnMarch 1st - MarketBeat

Mar 02, 2025
pulisher
Mar 02, 2025

Best Growth Stocks To Watch NowMarch 1st - MarketBeat

Mar 02, 2025
pulisher
Mar 02, 2025

There's No Escaping Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Muted Revenues Despite A 69% Share Price Rise - Simply Wall St

Mar 02, 2025
pulisher
Mar 02, 2025

Organogenesis (NASDAQ:ORGO) Sets New 52-Week High – Here’s What Happened - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Promising Growth Stocks To ConsiderFebruary 28th - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

ORGO stock touches 52-week high at $4.64 amid market fluctuations By Investing.com - Investing.com South Africa

Mar 01, 2025
pulisher
Feb 28, 2025

CGI Inc. (GIB) Stock Forecasts - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Organogenesis (NASDAQ:ORGO) Issues Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

ORGO stock touches 52-week high at $4.64 amid market fluctuations - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Today’s top stories: pain management innovation and revenue jumps - RagingBull

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald lifts Organogenesis price target to $6.00 By Investing.com - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald lifts Organogenesis price target to $6.00 - Investing.com

Feb 28, 2025

Organogenesis Holdings Inc Stock (ORGO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$27.00
price down icon 0.74%
$101.32
price up icon 0.80%
$7.56
price up icon 2.30%
$101.38
price up icon 1.28%
drug_manufacturers_specialty_generic RDY
$13.67
price up icon 1.71%
$284.73
price down icon 0.16%
Cap:     |  Volume (24h):